1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow Refractory Hairy Cell Leukemia: new trials by email Literature Review of Refractory Hairy Cell Leukemia trials Research Report on Refractory Hairy Cell Leukemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications internet-based intervention, questionnaire administration, psychosocial assessment and care - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission | Phase 3 | Completed | Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium | 1337 | 2008-08-01 | 2012-03-07 |
Blast Crisis (1) · Burkitt Lymphoma (1) · Congenital Abnormalities (1) · Depression (1) · Fatigue (1) · Hodgkin Disease (1) · Leukemia, Hairy Cell (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Leukemia, Myeloid, Accelerated Phase (1) · Leukemia, Myeloid, Acute (1) · Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative (1) · Leukemia, Myeloid, Chronic-Phase (1) · Leukemia, Myelomonocytic, Chronic (1) · Leukemia, Neutrophilic, Chronic (1) · Lymphoma, B-Cell, Marginal Zone (1)
Behavior (1) · Behavioral Symptoms (1) · Blood Protein Disorders (1) · Bone Marrow Diseases (1) · Carcinogenesis (1) · Cardiovascular Diseases (1) · Cell Transformation, Neoplastic (1) · Chronic Disease (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · DNA Virus Infections (1) · Disease Attributes (1) · Epstein-Barr Virus Infections (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Hemorrhagic Disorders (1)
Counseling (1) · Psychiatric Rehabilitation (1) · Therapeutics (1)
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium (1)
United States (1)
Karen Syrjala (1)
PMID 32628342, PMID 33420905, PMID 36282798
R01CA112631 (1)